As a result, any single immune marker was not related to survival rate, including CD8, which was a representative marker of CTL; FoxP3 in Treg; and PD-L1, which has been known as a prognostic marker in ovarian cancer but is under debate (Figure 3). The gene discussed is CD8A; the disease is ovarian carcinoma.